Compared to liposomal amphotericin B (3 mg/kg/day) what was the result of micafungin (100 mg/day for subjects > 40 kg; 2 mg/kg/day for subjects ≤ 40 kg) on treatment success in ICU subjects?
In non-ICU subjects, the treatment success rate was significantly higher among subjects receiving micafungin than liposomal amphotericin B (85% versus 72.1%; P = 0.0113).